Jennifer Cook, Catherine Friedman, Min Cui

Grail has appointed Jennifer Cook as CEO, effective Jan. 2, 2018. She will take over for Bill Rastetter, who has been serving as interim CEO. Rastetter will continue his role as chairman of the board of directors. Cook joins Grail from Roche, where she is currently head of clinical operations in product development for Roche Pharmaceuticals. Previously, she was head of the Europe region for Roche Pharmaceuticals, and has also held research and management positions at Genentech.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.